Literature DB >> 11817705

Histamine H1 receptor activation stimulates mitogenesis in human astrocytoma U373 MG cells.

A Hernández-Angeles1, L E Soria-Jasso, A Ortega, J A Arias-Montaño.   

Abstract

In human astrocytoma U373 MG cells that express histamine H1 receptors (180 +/- 6 fmol/mg protein) but not H2 or H3 receptors, histamine stimulated mitogenesis as assessed by [3H]-thymidine incorporation (173 +/- 2% of basal; EC50, 2.5 +/- 0.4 microM). The effect of 100 microM histamine was fully blocked by the selective H1 antagonist mepyramine (1 microM) and was markedly reduced (93 +/- 4% inhibition) by the phospholipase C inhibitor U73122 (10 microM). The activator of protein kinase C (PKC) phorbol 12-tetradecanoyl-13-acetate (TPA, 100nM) stimulated [3H]-thymidine incorporation (270 +/- 8% of basal), and this response was not additive with that to 100 microM histamine. The incorporation of [3H]-thymidine induced by 100 microM histamine was partially reduced by the PKC inhibitor Ro 31-8220 (57 +/- 7% inhibition at 300 nM) and by the compound PD 098,059 (30 microM, 62 +/- 14% inhibition), an inhibitor of the mitogen-activated kinase (MAPK) kinases MEK1/MEK2. These results show that histamine H1 receptor activation stimulates the proliferation of human astrocytoma U373 MG cells. The action of histamine appears to be partially mediated by PKC stimulation and MAPK activation.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11817705     DOI: 10.1023/a:1013338515229

Source DB:  PubMed          Journal:  J Neurooncol        ISSN: 0167-594X            Impact factor:   4.130


  52 in total

Review 1.  Quantitative aspects of reactive gliosis: a review.

Authors:  W T Norton; D A Aquino; I Hozumi; F C Chiu; C F Brosnan
Journal:  Neurochem Res       Date:  1992-09       Impact factor: 3.996

2.  Elevation of cyclic AMP levels in astrocytes antagonizes cytokine-induced adhesion molecule expression.

Authors:  M E Ballestas; E N Benveniste
Journal:  J Neurochem       Date:  1997-10       Impact factor: 5.372

3.  P2Y(2) receptor-mediated proliferation of C(6) glioma cells via activation of Ras/Raf/MEK/MAPK pathway.

Authors:  M T Tu; S F Luo; C C Wang; C S Chien; C T Chiu; C C Lin; C M Yang
Journal:  Br J Pharmacol       Date:  2000-04       Impact factor: 8.739

4.  The pathway to signal achievement.

Authors:  S E Egan; R A Weinberg
Journal:  Nature       Date:  1993-10-28       Impact factor: 49.962

Review 5.  Neurotransmitter transporters.

Authors:  D Attwell; P Mobbs
Journal:  Curr Opin Neurobiol       Date:  1994-06       Impact factor: 6.627

6.  Molecular cloning and characterization of a novel type of histamine receptor preferentially expressed in leukocytes.

Authors:  T Oda; N Morikawa; Y Saito; Y Masuho; S Matsumoto
Journal:  J Biol Chem       Date:  2000-11-24       Impact factor: 5.157

7.  Genistein, a specific inhibitor of tyrosine-specific protein kinases.

Authors:  T Akiyama; J Ishida; S Nakagawa; H Ogawara; S Watanabe; N Itoh; M Shibuya; Y Fukami
Journal:  J Biol Chem       Date:  1987-04-25       Impact factor: 5.157

8.  Guinea pig histamine H1 receptor. II. Stable expression in Chinese hamster ovary cells reveals the interaction with three major signal transduction pathways.

Authors:  R Leurs; E Traiffort; J M Arrang; J Tardivel-Lacombe; M Ruat; J C Schwartz
Journal:  J Neurochem       Date:  1994-02       Impact factor: 5.372

Review 9.  Peptide receptors in astroglia: focus on angiotensin II and atrial natriuretic peptide.

Authors:  C Sumners; W Tang; W Paulding; M K Raizada
Journal:  Glia       Date:  1994-06       Impact factor: 7.452

10.  Substance P activates responses correlated with tumour growth in human glioma cell lines bearing tachykinin NK1 receptors.

Authors:  C Palma; F Nardelli; S Manzini; C A Maggi
Journal:  Br J Cancer       Date:  1999-01       Impact factor: 7.640

View more
  7 in total

1.  Effects of antihistamine and anti-inflammatory medication use on risk of specific glioma histologies.

Authors:  Michael E Scheurer; E Susan Amirian; Stacy L Davlin; Terri Rice; Margaret Wrensch; Melissa L Bondy
Journal:  Int J Cancer       Date:  2011-04-04       Impact factor: 7.396

Review 2.  Molecular and cellular analysis of human histamine receptor subtypes.

Authors:  Roland Seifert; Andrea Strasser; Erich H Schneider; Detlef Neumann; Stefan Dove; Armin Buschauer
Journal:  Trends Pharmacol Sci       Date:  2012-12-17       Impact factor: 14.819

3.  Long-term anti-inflammatory and antihistamine medication use and adult glioma risk.

Authors:  Michael E Scheurer; Randa El-Zein; Patricia A Thompson; Kenneth D Aldape; Victor A Levin; Mark R Gilbert; Jeffrey S Weinberg; Melissa L Bondy
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2008-05       Impact factor: 4.254

4.  Inhibition of histamine receptor 3 suppresses glioblastoma tumor growth, invasion, and epithelial-to-mesenchymal transition.

Authors:  Jia-Ji Lin; Tian-Zhi Zhao; Wen-Ke Cai; Yong-Xiang Yang; Chao Sun; Zhuo Zhang; Yu-Qiao Xu; Ting Chang; Zhu-Yi Li
Journal:  Oncotarget       Date:  2015-07-10

5.  Proliferative Effects of Histamine on Primary Human Pterygium Fibroblasts.

Authors:  Zhenwei Qin; Qiuli Fu; Lifang Zhang; Houfa Yin; Xiuming Jin; Qiaomei Tang; Danni Lyu; Ke Yao
Journal:  Mediators Inflamm       Date:  2016-10-30       Impact factor: 4.711

6.  Glioblastoma cells express functional cell membrane receptors activated by daily used medical drugs.

Authors:  Susanne A Kuhn; Ulrike Mueller; Uwe-K Hanisch; Christian R A Regenbrecht; Ilona Schoenwald; Michael Brodhun; Hartwig Kosmehl; Christian Ewald; Rolf Kalff; Rupert Reichart
Journal:  J Cancer Res Clin Oncol       Date:  2009-06-19       Impact factor: 4.553

7.  Histamine: a new immunomodulatory player in the neuron-glia crosstalk.

Authors:  Sandra M Rocha; Joel Pires; Marta Esteves; Baltazar Graça; Liliana Bernardino
Journal:  Front Cell Neurosci       Date:  2014-04-30       Impact factor: 5.505

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.